Twist Bioscience Corp. (TWST)
114.22
-8.37
(-6.83%)
USD |
NASDAQ |
Nov 12, 16:00
114.70
+0.48
(+0.42%)
After-Hours: 06:32
Twist Bioscience Price : 114.22 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 99.72 | 114.97 | 93.68 | 114.22 | 5.303M |
| Nov 11, 2026 | 140.98 | 151.50 | 122.08 | 122.59 | 3.480M |
| Nov 10, 2026 | 133.44 | 138.06 | 125.01 | 132.13 | 1.719M |
| Nov 09, 2026 | 123.80 | 138.30 | 121.24 | 135.34 | 1.670M |
| Nov 06, 2026 | 123.83 | 130.90 | 116.50 | 120.79 | 2.055M |
| Nov 05, 2026 | 134.79 | 134.98 | 118.60 | 120.61 | 3.092M |
| Nov 04, 2026 | 140.78 | 142.98 | 131.32 | 142.58 | 2.007M |
| Nov 03, 2026 | 130.35 | 141.62 | 130.14 | 140.30 | 1.941M |
| Nov 02, 2026 | 153.17 | 154.22 | 128.29 | 129.04 | 2.674M |
| Oct 30, 2026 | 162.94 | 167.27 | 148.00 | 152.78 | 3.400M |
| Oct 29, 2026 | 170.43 | 177.99 | 169.07 | 173.45 | 1.778M |
| Oct 28, 2026 | 160.44 | 178.53 | 159.00 | 173.45 | 3.490M |
| Oct 27, 2026 | 145.74 | 162.61 | 143.70 | 159.85 | 1.758M |
| Oct 26, 2026 | 139.45 | 147.62 | 136.19 | 145.25 | 1.380M |
| Oct 23, 2026 | 132.95 | 140.74 | 131.23 | 139.92 | 1.858M |
| Oct 22, 2026 | 143.50 | 150.14 | 131.85 | 135.47 | 2.692M |
| Oct 21, 2026 | 139.34 | 153.80 | 138.25 | 149.13 | 2.636M |
| Oct 20, 2026 | 139.77 | 148.83 | 134.94 | 142.70 | 2.020M |
| Oct 19, 2026 | 136.99 | 141.80 | 133.72 | 139.77 | 1.593M |
| Oct 16, 2026 | 143.88 | 145.05 | 130.98 | 132.75 | 2.831M |
| Oct 15, 2026 | 138.09 | 148.32 | 130.68 | 144.49 | 3.543M |
| Oct 14, 2026 | 146.69 | 156.00 | 144.79 | 148.16 | 2.123M |
| Oct 13, 2026 | 149.00 | 154.23 | 146.00 | 151.33 | 1.530M |
| Oct 12, 2026 | 159.78 | 161.80 | 147.55 | 151.86 | 2.652M |
| Oct 09, 2026 | 152.69 | 168.93 | 152.14 | 159.78 | 3.541M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 10.55 |
| Beam Therapeutics, Inc. | 24.03 |
| 10X Genomics, Inc. | 59.10 |
| Moderna, Inc. | 231.35 |
| Prime Medicine, Inc. | 3.89 |
Price Related Metrics
| PS Ratio | 16.24 |
| PEG Ratio | -0.9659 |
| Price to Book Value | 16.06 |
| Earnings Yield | -1.55% |
| Market Cap | 7.159B |
| PEGY Ratio | -0.9659 |